Australian Life Sciences Stock News

ASX:TOE
ASX:TOEOil and Gas

ASX Penny Stocks To Watch In December 2025

As Australian shares edge towards a modest gain, the market's recent volatility has kept investors on their toes, with fluctuations throughout the week reflecting a cautious sentiment. For those interested in exploring smaller or newer companies, penny stocks remain an intriguing option despite their somewhat antiquated name. These stocks can offer surprising value when backed by strong financials and growth potential, providing opportunities for investors to discover promising candidates...
ASX:CPU
ASX:CPUProfessional Services

Computershare (ASX:CPU): Assessing Valuation After a Recent Pullback From Its Highs

Computershare (ASX:CPU) has quietly pulled back over the past month, shedding about 5% and now sitting roughly 7% below recent highs. This naturally raises the question: does this dip offer fair value? See our latest analysis for Computershare. That pullback comes after a solid run, with the share price delivering a modest year to date gain while total shareholder returns over five years remain very strong. This suggests momentum is pausing rather than breaking. If Computershare’s move has...
ASX:PMV
ASX:PMVSpecialty Retail

Is Premier Investments' A$100m Buyback (ASX:PMV) A Sign Of Discipline Or Fewer Growth Options?

Premier Investments Limited (ASX:PMV) recently authorised a share repurchase program of up to A$100,000,000 of its ordinary shares, running until 23 December 2025 and targeting earnings per share accretion and higher shareholder returns. This buyback meaningfully reduces Premier’s share count potential from its 159,879,998 issued shares, signalling management’s confidence in the company’s capital position and cash generation. Next, we’ll examine how Premier’s A$100,000,000 buyback plan...
ASX:6KA
ASX:6KAMetals and Mining

6K Additive (ASX:6KA) Loss Deepens, Reinforcing Bearish Cash Runway and Balance Sheet Concerns

6K Additive (ASX:6KA) has released its H1 2025 numbers, posting total revenue of about $9.7 million alongside a net loss of roughly $12.8 million. This leaves investors weighing modest top line progress against ongoing red ink. The company has seen revenue move from around $7.7 million in H1 2024 to $9.7 million in H1 2025. Meanwhile, trailing 12 month revenue sits near $20.4 million against a net loss of about $26.6 million, underscoring a business that is expanding sales but still running...